ECR - Volume 9 Issue 2 Winter 2014
Prof Juan Carlos Kaski and the Editorial Board present Volume 9 Issue 2 of European Cardiology Review.
This issue comprises a range of reviews and expert opinion articles covering extremely important topics in cardiovascular medicine. Topics covered include the emerging role of PCSK9 inhibitors in preventive cardiology, diagnosis and risk stratification in Brugada syndrome, the role of renal denervation, gaps in heart failure guidelines and the management of familial hypercholesterolaemia.
Foreword
Citation: European Cardiology Review 2014;9(2):64.
Coronary Artery Disease Prevention
Citation: European Cardiology Review 2014;9(2):65–70
Citation: European Cardiology Review 2014;9(2):71–5
Cameron T Lambert
,
Pratik Sandesara
,
Ijeoma Isiadinso
,
Maria Carolina Gongora
,
Danny Eapen
,
Neal Bhatia
,
Jefferson T Baer
,
Laurence S Sperling
,
Citation: European Cardiology Review 2014;9(2):76–81
Risk Assessment and Management
Citation: European Cardiology Review 2014;9(2):82–7
Lee Chang
,
Robert Yeh
,
Citation: European Cardiology Review 2014;9(2):88–91
Citation: European Cardiology Review 2014;9(2):92–9
Heart Failure
Citation: European Cardiology Review 2014;9(2):100–3
Citation: European Cardiology Review 2014;9(2):104–9
Hypertension
Alexandre Persu
,
Fadl Elmula M Fadl Elmula
,
Yu Jin
,
Ingrid Os
,
Sverre E Kjeldsen
,
Jan A Staessen
,
Citation: European Cardiology Review 2014;9(2):110–4
Citation: European Cardiology Review 2014;9(2):115–20
Supported Contribution – Opinion
Citation: European Cardiology Review 2014;9(2):120–2